登录

Vedeng Medical Closes ¥100M Series B Round, To Build An Ecosystem of the Whole Medical Device Industry Chain

作者: Mailman 2020-05-12 14:01
贝登医疗
http://www.vedeng.com
企业数据由 动脉橙 提供支持
医疗器械供应商 | B轮 | 运营中
中国-江苏
2020-05-11
融资金额:RMB¥1亿
创新工场
查看

According to VCBeat, Nanjing Vedeng Medical Co., Ltd. ("Vedeng Medical"), a leading B2B eCommerce platform of medical devices in China, has recently completed a Series B financing of 100 million led by Sinovation Ventures. CEC Capital acted as the exclusive financial adviser to Vedeng Medical in this round.


Proceeds from the latest round will be used to develop the digital platform of Vedeng Medical, improve localization services and the integration of upstream supply chain, promote logistics, warehousing, after-sales services, and marketing, expand the coverage of products, and explore in the specialized and overseas market, to finally build an online ecosystem of the whole industry chain for medical device providers.


Vedeng Medical has been engaged in the field of medical equipment in 2015. In view of the problems of the domestic circulation industry such as the traditional and inefficient mode of purchasing and selling, information asymmetry, undisclosed price, Vedeng Medical takes "To Make the Medical Device Purchase More Simple" as a long-standing mission.


By utilizing its proprietary B2B business model, Vedeng Medical builds a connection between the upstream manufacturers of medical equipment and the downstream dealers and medical service providers, to provide the most cost-effective products for the majority of private and primary medical institutions, therefore promote the medical service cost reduction quality improvement of the whole society.


>>>>

About Sinovation Ventures


Sinovation Ventures is a leading Chinese technology venture capital, started in 2009 by a team led by Dr. Kai-Fu Lee, with presences in Beijing, Shanghai, Nanjing, Guangzhou, and Shenzhen. It currently manages over $2B AUM between seven USD and RMB funds in total, and over 350 portfolio companies across the technology spectrum in China. The company invests in start-ups at the seed, Series A and Series B stages. 


>>>>

About CEC Capital


Founded in 2000, CEC Capital (formerly known as China eCapital Corporation) is a leading investment bank in China with a core focus on the TMT, consumer and healthcare sectors. Headquartered in Beijing with offices in Shanghai, Los Angeles and San Francisco, CEC Capital provides M&A, capital raising, and asset management services to clients both in and outside of China.

相关赛道 药械流通
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】贤石生物完成数千万元 A 轮融资,首款子宫内膜修复产品注册临床第一例受试者入组

Tianhong Shengjie Completes ¥10M Series A + Financing

MicroMedTec Closes on¥10M Pre-A Round, with its Aneurysm Sealing Product into Clinical Trails

Minkang Bio Closes ¥150M Pre-IPO Funding Round

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Online Mental Health Service Platform Haoxinqing Snares¥125M in Series A Funding Round

2020-05-12
下一篇

红杉投资的新产业生物登陆A股,中国IVD领军者助力全球抗疫

2020-05-12